AB0428 Study on the Efficacy and Safety of Tocilizumab in Patients with Rheumatoid Arthritis in Slovakia: One Year Results of Prospective, Open Label Study Close to Clinical Practice

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 948.3-949
Author(s):  
I. Rybar ◽  
Z. Killinger ◽  
Z. Macejova ◽  
Z. Kmecova ◽  
E. Zanova ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Practice ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
One Year

scholarly journals Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis

BioDrugs ◽  
2017 ◽  
Vol 31 (4) ◽  
pp. 369-377 ◽  
Author(s):  
Won Park ◽  
Chang-Hee Suh ◽  
Seung Cheol Shim ◽  
Francisco Fidencio Cons Molina ◽  
Slawomir Jeka ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

The Effect of Fenoprofen Calcium (Nalfon) on Levels of Rheumatoid Factor in Patients with Rheumatoid Arthritis

1973 ◽  
Vol 1 (2) ◽  
pp. 412-416
Author(s):  
Joan E Himes ◽  
Ivan F Duff
Keyword(s):  
Rheumatoid Arthritis ◽  
Rheumatoid Factor ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
The Mean ◽  
Baseline Levels ◽  
One Year

In 88.9% of a group of 18 patients with rheumatoid arthritis participating in an open-label study with fenoprofen calcium (Nalfon), there was observed a mean litre decrease in level of rheumatoid factor as compared to baseline levels. In follow-up, three months to one year later, a uniform litre increase above the mean level of the study period had occurred. In all cases the titre returned to baseline levels or higher.

scholarly journals Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

2012 ◽  
Vol 71 (12) ◽  
pp. 1950-1954 ◽  
Author(s):  
Vivian P Bykerk ◽  
Andrew J K Östör ◽  
José Alvaro-Gracia ◽  
Karel Pavelka ◽  
José Andrés Román Ivorra ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Practice ◽  
Active Rheumatoid Arthritis ◽  
Tnf Inhibitors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice

2019 ◽  
Vol 38 (9) ◽  
pp. 2411-2421 ◽  
Author(s):  
Vivian P. Bykerk ◽  
Andrew J. K. Östör ◽  
José Alvaro-Gracia ◽  
Karel Pavelka ◽  
José Andrés Román Ivorra ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Practice ◽  
Tnf Inhibitors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study

2019 ◽  
Vol 3 (1) ◽  
Author(s):  
John D Isaacs ◽  
Abdelrazig Salih ◽  
Thomas Sheeran ◽  
Yusuf I Patel ◽  
Karen Douglas ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Real World ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study

2015 ◽  
Vol 27 (4) ◽  
pp. 371 ◽  
Author(s):  
Jung-Min Park ◽  
Hyun-Ho Cho ◽  
Won-Jeong Kim ◽  
Je-Ho Mun ◽  
Margaret Song ◽  
...  
Keyword(s):  
Betamethasone Dipropionate ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Calcipotriol Betamethasone
Sign in / Sign up

Export Citation Format

Share Document